Concomitant medical products: product id: 977a260, serial#: (b)(4), implanted: (b)(6) 2019, product type: lead.Product id: 977a260, serial#: (b)(4), implanted: (b)(6) 2019, product type: lead.Other relevant device(s) are: product id: 977a260, serial/lot #: (b)(4), ubd: 09-jan-2023, udi#: (b)(4) ; product id: 977a260, serial/lot #: (b)(4), ubd: 12-dec-2022, udi#: (b)(4).If information is provided in the future, a supplemental report will be issued.
|
Information was received from a consumer via a manufacturer representative (rep) regarding a patient with an implantable neurostimulator (ins).It was reported that the patient called the rep on (b)(6) 2019, to meet for a normal reprogramming.When the patient met with the patient on (b)(6) 2019, the patient said he had cupping done by his physical therapist on (b)(6) 2019, and since that appointment, the patient has had intermittent nausea and dizziness/balance issues.The patient said he's tried turning the stimulator on and off and seems to find a correlation between the symptoms and when the ins on.The patient never had any issues before the cupping appointment.The patient said they specifically told the physical therapist to not go down his spine with the technique, but they did nonetheless.Impedances were normal and connectivity tests showed no issues.An x-ray was done and noticed that one of the two leads had migrated, but it was of an insubstantial amount.No other visible damage on the x-ray or any other indicators that the scs system was comprised of.The rep tried a different program and asked the patient to run it at a lower amount than he had previously to see if those symptoms return as he was running it quite a bit higher than previously.The rep was going to re-evaluate with the patient a week following the report.The patient was told if the symptoms come on, to turn the device off and contact the rep again.No further complications were reported.
|